// App-Quantinova.ai

: PONATINIB IN CHILDHOOD PHILADELPHIA POSITIVE LEUKEMIAS: THE EXPERIENCE OF THE INTERNATIONAL REGISTRY OF CHILDHOOD CHRONIC MYLELOID LEUKEMIA (I-CML-PED-STUDY).

Researchers

Presenter

  • Frederic Millot

Principal Investigators

  • Meinolf Suttorp

  • Eveline de Bont

  • Krzysztof Kalwak

  • Brigitte Nelken

  • Stephane Ducassou

  • Yves Bertrand

  • Andr Baruchel

Medical Centers

  • Inserm CIC 1402, University Hospital, Poitiers, France

  • Medical Faculty, Pediatric Hemato-oncology,Technical University,Dresden,France

  • Department of Pediatric Oncology/Hematology, Beatrix Childrens Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

  • Department of Pediatric Hematology Oncology and Transplantation,Department of Pediatric HematologyWroclaw Medical University,Wroclaw,Poland

  • Department of Pediatric hematology-oncology,University Hospital,Lille,France

  • Department of Pediatric hematology-oncology,University Hospital,Lille,France

  • department of pediatric hematology,Institut d’Hématologie et d’Oncologie Pédiatrique,Lyon,France

  • Department of Pediatric Hematology-Immunology, Robert Debre Hospital, Paris, France

Locations

  • France

  • Netherlands

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Ponatinib

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved